Toxina Shiga Escherichia coli

De Viquipèdia
Dreceres ràpides: navegació, cerca

La toxina Shiga Escherichia coli (en anglès:Shiga Toxine Escherichia Coli, STEC) és un bacteri responsable de les colitis hemorràgiques i de la síndrome hemolítica i urèmica.

Es tracta de la nova definició internacionali es coneix també sota altres noms com enterohemorrhagic E. coli (EHEC), Shiga-like toxin-producing E. coli (SLTEC ou STEC), hemolytic uremic syndrome–associated enterohemorrhagic E. coli (HUSEC) i verocytotoxin- o verotoxin-producing E. coli (VTEC).[1]

Shiga fa referència a Kiyoshi Shiga qui descobrí Shigella dysenteriae un dels bacteris del gènere shigella.

Referències[modifica | modifica el codi]

  1. Karch H; Tarr P; Bielaszewska M. «Enterohaemorrhagic Escherichia coli in human medicine» (en anglès). Int J Med Microbiol, 295, núm. 6-7, 5 octubre 2005, pàg. 405–18. DOI: 10.1016/j.ijmm.2005.06.009. PMID: 16238016.

Bibliografia[modifica | modifica el codi]

  • (francès) * AFSSA (2003) Bilan des connaissances relatives aux Escherichia coli producteurs de Shiga-toxines (STEC).
  • (francès) MONTET, Marie-Pierre Thèse en ligne : Contamination des aliments par les Escherichia coli producteurs de Shiga-toxines (STEC) en France, et importance de l'acido-résistance des souches, École Pratique des Hautes Études, Sorbonne, 3 juin 2009
  • (anglès) Acton, D.F. and Gregorich, L.J. (1995) The Health of our Soils: Toward sustainable agriculture in Canada. Agriculture and Agri-Food Canada.
  • Barua, S., Yamashino, T., Hasegawa, T., Yokoyama, K., Torii, K. and Ohta, M. (2002) Involvement of surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli O157:H7. Mol Microbiol. 43: 629-640.
  • Bertin, Y., Boukhors, K., Pradel, N., Livrelli, V. and Martin, C. (2001) Stx2 subtyping of Shiga toxinproducing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors. J Clin Microbiol. 39: 3060-3065
  • Beutin, L., Zimmermann, S. and Gleier, K. (1996) Rapid detection and isolation of shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay. J Clin Microbiol. 34: 2812-2814
  • Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shigatoxin producing strains of Escherichia coli (STEC) from food and other sources. J Appl Microbiol. 102: 630-639
  • Boerlin, P. (1999) Evolution of virulence factors in Shiga-toxin-producing Escherichia coli. Cell Mol Life Sci. 56: 735-741
  • Brett, K.N., Hornitzky, M.A., Bettelheim, K.A., Walker, M.J. and Djordjevic, S.P. (2003) Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx2-EDL933 and/or stx2vhb subtypes. J Clin Microbiol. 41: 2716-2722.
  • Cebula, T.A., Payne, W.L. and Feng, P. (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assaymultiplex PCR. J Clin Microbiol. 33: 248-250.
  • Cookson, A.L., Cooley, W.A. and Woodward, M.J. (2002) The role of type 1 and curli fimbriae of Shiga toxin-producing Escherichia coli in adherence to abiotic surfaces. Int J Med Microbiol. 292: 195-205
  • Decludt, B., Bouvet, P., Mariani-Kurkdjian, P., Grimont, F., Grimont, P.A., Hubert, B., et al (2000) Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. Epidemiol Infect. 124: 215-220.
  • Erwert, R.D., Eiting, K.T., Tupper, J.C., Winn, R.K., Harlan, J.M. and Bannerman, D.D. (2003) Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. Microb Pathog. 35: 87-93.
  • Espié, E., Grimont, F., Mariani-Kurkdjian, P., Bouvet, P., Haeghebaert, S., Filliol, I., et al (2008) Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J. 27: 595-601.
  • Fach, P., Perelle, S., Dilasser, F. and Grout, J. (2001) Comparison between a PCR-ELISA test and the vero cell assay for detecting Shiga toxin-producing Escherichia coli in dairy products and characterization of virulence traits of the isolated strains. J Appl Microbiol. 90: 809-818.
  • Fernandez, G.C., Lopez, M.F., Gomez, S.A., Ramos, M.V., Bentancor, L.V., Fernandez-Brando, R.J., et al (2006) Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol. 146: 76-84.
  • Fiorito, P., Burgos, J.M., Miyakawa, M.F., Rivas, M., Chillemi, G., Berkowski, D., et al (2000) Effect of Shiga toxin 2 on water and ion transport in human colon in vitro. Dig Dis Sci. 45: 480-486.
  • Foster, G.H., Armstrong, C.S., Sakiri, R. and Tesh, V.L. (2000) Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect Immun. 68: 5183-5189
  • Gannon, V.P., Teerling, C., Masri, S.A. and Gyles, C.L. (1990) Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J Gen Microbiol. 136: 1125-1135.
  • Gerber, A., Karch, H., Allerberger, F., Verweyen, H.M. and Zimmerhackl, L.B. (2002) Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis. 186: 493-500.
  • Gourmelon, M., Montet, M.P., Lozach, S., Le Mennec, C., Pommepuy, M., Beutin, L. and Vernozy- Rozand, C. (2006) First isolation of Shiga toxin 1d producing Escherichia coli variant strains in shellfish from coastal areas in France. J. Appl. Microbiol. 100: 85-97.
  • Greatorex, J.S. and Thorne, G.M. (1994) Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharidein hemolytic-uremic syndrome patients and healthy subjects. Journal of Clinical Microbiology. 32: 1172-1178.
  • Hurley, B.P., Jacewicz, M., Thorpe, C.M., Lincicome, L.L., King, A.J., Keusch, G.T. and Acheson, D.W. (1999) Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun. 67: 6670-6677.
  • Jenkins, C., Perry, N.T., Cheasty, T., Shaw, D.J., Frankel, G., Dougan, G., et al (2003) Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins. J Clin Microbiol. 41: 1775-1778.
  • Klie, H., Timm, M., Richter, H., Gallien, P., Perlberg, K.W. and Steinruck, H. (1997) Detection and occurrence of verotoxin-forming and/or shigatoxin producing Escherichia coli (VTEC and/or STEC) in milk. . Berl Munch Tierarztl Wochenschr. 110: 337-341.
  • Lea, N., Lord, J.M. and Roberts, L.M. (1999) Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157:H7 Shiga-like toxin-1. Microbiology. 145 ( Pt 5): 999-1004.
  • Louise, C.B. and Obrig, T.G. (1995) Specific interaction of Escherichia coli O157:H7 derived Shigalike toxin II with human renal endotheial cells. Journal of Infections diseases. 172: 1397-1401
  • Ludwig, K., Petric, M., Blanchette, V. and Karmali, M. (1998) Isolated thrombocytopenic purpura associated with infection due to verocytotoxin (Shiga toxin)-producing Escherichia coli serotype O26:H11. Clin Infect Dis. 27: 660-661.
  • O'Brien, S.J., Adak, G.K. and Gilham, C. (2001a) Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans. Emerg Infect Dis. 7: 1049-1051.
  • Pal, A., Ghosh, S., Ramamurthy, T., Yamasaki, S., Tsukamoto, T., Bhattacharya, S.K., et al (1999) Shiga-toxin producing Escherichia coli from healthy cattle in a semi-urban community in Calcutta, India. Indian J Med Res. 110: 83-85
  • Paton, A.W., Srimanote, P., Woodrow, M.C. and Paton, J.C. (2001) Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun. 69: 6999-7009.
  • Sandvig, K. (2001) Shiga toxins. Toxicon. 39: 1629-1635.
  • Schuller, S., Frankel, G. and Phillips, A.D. (2004) Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell Microbiol. 6: 289-301.
  • Strockbine, N.A., Jackson, M.P., Sung, L.M., Holmes, R.K. and O'Brien, A.D. (1988) Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol. 170: 1116-1122.
  • Thorpe, C.M., Smith, W.E., Hurley, B.P. and Acheson, D.W. (2001) Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun. 69: 6140-6147.
  • Vernozy-Rozand, C., Montet, M.P., Berardin, M., Bavai, C. and Beutin, L. (2005a) Isolation and characterization of Shiga toxin-producing Escherichia coli strains from raw milk cheeses in France. Lett. Appl. Microbiol. 41: 235-241.
  • Vernozy-Rozand, C., Montet, M.P., Bertin, Y., Trably, F., Girardeau, J.P., Martin, C., et al (2004) Serotyping, stx2 subtyping, and characterization of the locus of enterocyte effacement island of shiga toxin-producing Escherichia coli and E. coli O157:H7 strains isolated from the environment in France. Appl Environ Microbiol. 70: 2556-2559.

Enllaços externs[modifica | modifica el codi]